Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.380
+0.010 (0.42%)
At close: Jun 26, 2026, 4:00 PM EDT
2.340
-0.040 (-1.68%)
After-hours: Jun 26, 2026, 4:55 PM EDT
Grace Therapeutics Employees
Grace Therapeutics had 5 employees as of March 31, 2026. The number of employees decreased by 1 or -16.67% compared to the previous year.
Employees
5
Change (1Y)
-1
Growth (1Y)
-16.67%
Revenue / Employee
n/a
Profits / Employee
-$1,558,600
Market Cap
38.73M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Aligos Therapeutics | 82 |
| Senti Biosciences Holdings | 39 |
| INmune Bio | 21 |
| ABVC BioPharma | 19 |
| RenovoRx | 17 |
| Apollomics | 14 |
| Nutriband | 13 |
| Actuate Therapeutics | 12 |
GRCE News
- 9 days ago - Grace Therapeutics reports FY26 EPS (47c) vs (79c) last year - TheFly
- 9 days ago - Grace Therapeutics Announces 2026 Fiscal Year-End Financial Results, Provides Business Update - GlobeNewsWire
- 9 days ago - Grace Therapeutics Annual report: Q4 2026 - Filings
- 9 days ago - Grace Therapeutics Earnings release: Q4 2026 - Filings
- 9 days ago - Grace Therapeutics Slides: Corporate presentation - Filings
- 2 months ago - Grace Therapeutics price target lowered to $4 from $11 at Craig-Hallum - TheFly
- 2 months ago - Grace Therapeutics price target lowered to $8 from $12 at TD Cowen - TheFly
- 2 months ago - Grace Therapeutics down 48% after receipt of CRL from FDA for GTx-104 - TheFly